Bourse falls on Friday as a pullback in gold sends miners tumbling; reports Kevin Warhs tipped as next Fed boss weighs on $A; Nine acquires QMS for $850m; ResMed beats consensus. Follow live.

Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $279.86, with a ...

Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...

Resmed (NYSE: RMD) shares ticked up before hours today on second-quarter results that came in ahead of the consensus forecast ...

ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.

Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP ...

ResMed founder Dr. Peter Farrell has received the Horatio Alger Award, recognizing his contributions to respiratory care and ...

Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting sales, rather than hurting them.

A sudden reversal in sky-high commodity prices and talk of a new US Federal Reserve Chair weighed on the Australian market ...

KUALA LUMPUR, Malaysia--Malaysia and Singapore are finalizing the "master plan" for a special economic zone that has already netted over $17 billion in investment. The Johor-Singapore Special Economic ...

ResMed’s latest result highlights improved profitability and continued resilience in sleep and respiratory care markets, ...